Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Clinical Rehabilitation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Treig, T.
Right arrow Articles by Hesse, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Treig, T.
Right arrow Articles by Hesse, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study

Thomas Treig

Neurlogisches Therapiezentrum Greifswald, Free University Berlin, Germany

Cordula Werner

Klinik Berlin, Department of Neurological Rehabilitation, Free University Berlin, Germany

Martin Sachse

Neurlogisches Therapiezentrum Greifswald, Free University Berlin, Germany

Stefan Hesse

Klinik Berlin, Department of Neurological Rehabilitation, Free University Berlin, Germany

Objective: To assess the effect of D-amphetamine on the recovery of activities of daily living and motor functions after stroke,

Design: Randomized, placebo-controlled study,

Setting: Inpatient rehabilitation centre,

Subjects: Twenty-four stroke survivors after a first ischaemic supratentorial stroke within six weeks before study onset, severely to moderately affected, with a Barthel Index (0–100) ranging from 25 to 50, no severe concomitant internal, neurological or psychiatric diseases, and participating in a comprehensive rehabilitation programme of 10–12 weeks,

Interventions: Ten sessions with 10 mg D-amphetamine (or placebo) every fourth day totalling 100 mg in a time period of 36 days combined with physical therapy according to the neurodevelopmental concept within 60 minutes after drug intake.

Main outcome measures: Barthel Index (0–100) served as the primary outcome measure and the Rivermead Motor Assessment Score with its three sections (gross function, leg and trunk, and arm) as the secondary outcome measure, assessed at days 0, 20, 36, 90, 180 and 360.

Results: The two groups did not differ with respect to clinical data and outcome measures at study onset. All patients improved significantly except for arm function over the intervention period and up to day 90 after study onset. The comparison between groups did not reveal any difference at any time; amphetamine-treated patients did not show any increase in motor function or ADL compared with the control group.

Conclusions: The placebo-controlled study failed to show any effect of D-amphetamine on stroke recovery compared with control. The small number of patients, the timing and content of physical therapy were limiting factors of the present study. Further trials are warranted.

Clinical Rehabilitation, Vol. 17, No. 6, 590-599 (2003)
DOI: 10.1191/0269215503cr653oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
L. B. Goldstein
Amphetamine Trials and Tribulations
Stroke, March 1, 2009; 40(3_suppl_1): S133 - S135.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. L. Adkins, T. Schallert, and L. B. Goldstein
Poststroke Treatment: Lost in Translation
Stroke, January 1, 2009; 40(1): 8 - 9.
[Full Text] [PDF]


Home page
StrokeHome page
C. M. Papadopoulos, S.-Y. Tsai, V. Guillen, J. Ortega, G. L. Kartje, and W. A. Wolf
Motor Recovery and Axonal Plasticity With Short-Term Amphetamine After Stroke
Stroke, January 1, 2009; 40(1): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
S. Zittel, C. Weiller, and J. Liepert
Citalopram Improves Dexterity in Chronic Stroke Patients
Neurorehabil Neural Repair, June 1, 2008; 22(3): 311 - 314.
[Abstract] [PDF]


Home page
Cereb CortexHome page
F. Meintzschel and U. Ziemann
Modification of Practice-dependent Plasticity in Human Motor Cortex by Neuromodulators
Cereb Cortex, August 1, 2006; 16(8): 1106 - 1115.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
U. Ziemann, F. Meintzschel, A. Korchounov, and T. V. Ilic
Pharmacological Modulation of Plasticity in the Human Motor Cortex
Neurorehabil Neural Repair, June 1, 2006; 20(2): 243 - 251.
[Abstract] [PDF]


Home page
StrokeHome page
D. J. Gladstone, C. J. Danells, A. Armesto, W. E. McIlroy, W. R. Staines, S. J. Graham, N. Herrmann, J. P. Szalai, S. E. Black, and for the Subacute Therapy with Amphetamine and Reha
Physiotherapy Coupled With Dextroamphetamine for Rehabilitation After Hemiparetic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial
Stroke, January 1, 2006; 37(1): 179 - 185.
[Abstract] [Full Text] [PDF]



Advertisement